Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
Aidoc announced the FDA has allowed the use of their cleared AI algorithms intended for adjunctive use in the detection of findings associated with COVID-19.
read more
ARTMS and Telix have entered into a development collaboration agreement to employ ARTMS’ high activity production of Gallium-68 for Telix’s prostate cancer imaging product TLX591-CDx for imaging of prostate cancer with PET.
read more
Fortress Biotech announced Oncogenuity has an agreement with Columbia University to develop novel oligonucleotides for the treatment of genetically driven cancers.
read more
Adare Pharmaceuticals has acquired pharmaceutical technology company, Orbis Biosciences.
read more
BrightInsight and CSL Behring announced a global digital health partnership to provide digitally-enhanced treatment experiences and regulated digital health offerings to support CSL Behring therapies.
read more
Aleafia Health’s indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices (EU-GMP) certification.
read more
AI VIVO is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the Company as “top-ranked” for COVID-19.
read more
MediWound announced the expansion of its NexoBrid® European presence with distribution agreements with GENFA MEDICA and Specialty Therapeutics.
read more
AMRI has announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic.
read more
The Wasdell Group has announced a multi-million-pound investment in new packaging equipment across its sites in the UK and Ireland.
read more
Hovione announced the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more
Arcturus and Catalent have announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate intended to protect against the SARS-CoV-2 coronavirus.
read more